Gender and contemporary risk of adverse events in atrial fibrillation

Cardiovascular Risk and Diseases

Bempedoic Acid Reduces the Risk of Major Adverse Cardiovascular Events Across Patient Subgroups

Cardiovascular Risk and Diseases

Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors

Cardiovasc Diabetol

Zhang XR, Zhong WF, Liu RY, Huang JL, Fu JX, Gao J, Zhang PD, Liu D, Li ZH, He Y, Zhou H, Li Z

doi: 10.1186/s12933-025-02711-x

Atrial FibrillationHeart Failure

Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study

Circ Arrhythm Electrophysiol

Xing LY, Højberg S, Krieger DW, Graff C, Olesen MS, Healey JS, McIntyre WF, Brandes A, Køber L, Haugan KJ, Svendsen JH, Diederichsen SZ

doi: 10.1161/CIRCEP.124.012764

Atrial Fibrillation

Impact of Atrial Fibrillation and Atrial Fibrillation Therapies on Sports Performance in Athletes

Heart Rhythm

Khan AK, Lee HJ, Hills MT, Moss M, Lara B, Baumann R, Brandt C, Lampert R

doi: 10.1016/j.hrthm.2024.11.020

Atrial FibrillationThrombosis and Stroke

Sex Differences and 2-Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register-Based Study in Sweden

J Am Heart Assoc

Al Khatib I, Viktorisson A, Abzhandadze T, Sunnerhagen KS

doi: 10.1161/JAHA.124.037608

Cardiovascular Risk and Diseases

ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD

Eur Respir J

Wade RC, Martinez FJ, Criner GJ, Tombs L, Lipson DA, Halpin DMG, Han MK, Singh D, Wise RA, Kalhan R, Dransfield MT

doi: 10.1183/13993003.00171-2024

Atrial FibrillationThrombosis and Stroke

Prediction of atrial fibrillation after a stroke event: a systematic review with meta-analysis

Heart Rhythm

Helbitz A, Haris M, Younsi T, Romer E, Ginks W, Raveendra K, Hayward C, Shuweihdi F, Larvin H, Cameron A, Wu J, Buck B, Lip GYH, Nadarajah R, Gale CP

doi: 10.1016/j.hrthm.2025.01.026

Atrial FibrillationFurther Publications

Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk

JAMA Cardiol

Vad OB, Monfort LM, Paludan-Müller C, Kahnert K, Diederichsen SZ, Andreasen L, Lotta LA, Nielsen JB, Lundby A, Svendsen JH, Olesen MS, Geisinger MyCode Community Health Initiative and the Regeneron Genetics Center (RGC) Research Team

doi: 10.1001/jamacardio.2024.1528

Atrial Fibrillation

Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study

BMJ

Vinter N, Cordsen P, Johnsen SP, Staerk L, Benjamin EJ, Frost L, Trinquart L

doi: 10.1136/bmj-2023-077209

Related content

Bempedoic Acid Reduces the Risk of Major Adverse Cardiovascular Events Across Patient Subgroups

Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors

Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study

Impact of Atrial Fibrillation and Atrial Fibrillation Therapies on Sports Performance in Athletes

Sex Differences and 2-Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register-Based Study in Sweden

ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD

Prediction of atrial fibrillation after a stroke event: a systematic review with meta-analysis

Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk

Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study